Nathalie Zeitouni, MD, FAAD

Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.

Drs Sarah Arron and Nathalie Zeitouni share their insights into how they define locally advanced basal cell carcinoma and when they introduce multidisciplinary care.

Sarah Arron, MD, PhD, and Nathalie Zeitouni, MD, FAAD, discuss their approaches to managing patients with newly diagnosed basal cell carcinoma and highlight the negative consequences of a delayed diagnosis.